{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"14.660","floor":"13.160"},"ipodate":{"start":"2020-06-29 00:00:00","end":"2020-07-03 00:00:00"},"minimumcapital":"7403.87","subscribed":"1895.76","marketcap":"84.33億","H_marketcap":"--","pe":"--","codesrate":"5.00","link":"https://staticpdf.iqdii.com/stockdata/notice/01477/2020/2020062900094_c.pdf","ipopricing":"14.660","resultdate":"2020-07-09 00:00:00","enddate":"2020-07-03 00:00:00","listeddate":"2020-07-10 00:00:00","issuenumber":"10593.00萬","issuenumberhK":"5296.50萬","issuenumberother":"5296.50萬","grayprice":"43.90","sponsors":"摩根士丹利亞洲有限公司,高盛(亞洲)有限責任公司","raisemoney":"142397.00萬","use":"1、約427.19百萬港元（即所得款項凈額的30.00%）將用于我們的核心產品OT401；\n2、約711.98百萬港元（即所得款項凈額的50.00%）將用于其他候選藥物；\n3、約142.40百萬港元（即所得款項凈額的10.00%）將用于根據我們與當地政府所訂合作協議收購蘇州的制造設施；\n4、約142.40百萬港元（即所得款項凈額的10.00%）將用作營運資金及用于其他一般公司用途。","shares":500,"leadagent":"摩根士丹利亞洲有限公司,高盛(亞洲)有限責任公司,瑞士銀行香港分行","bookrunners":"摩根士丹利亞洲有限公司,高盛(亞洲)有限責任公司,瑞士銀行香港分行","coordinator":"摩根士丹利亞洲有限公司,高盛(亞洲)有限責任公司,瑞士銀行香港分行","firstDayOpen":"43.00","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"摩根士丹利亞洲有限公司","code":"E01477","name":"歐康維視生物－Ｂ","fullname":"歐康維視生物"},"institutioninfo":{"principaloffice":"中國上海市靜安區石門一路211號旺旺大廈502-1室","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"陳連勇","secretary":"季蕓,孫佩真","telephone":"(8621)) 6149 3800","substantialshareholders":"6 Dimensions實體(45.37%),Summer Iris Limited(13.6%),TLS Beta\nPte. Ltd.(9.47%)","principalactivities":"公司是一家中國眼科醫藥平臺公司，致力于識別、開發和商業化同類首創或同類最佳的眼科療法。","website":"http://www.ocumension.com"},"managerinfo":[{"managername":"陳連勇","post":"主席兼執行董事","rankno":1},{"managername":"劉曄","post":"首席執行官兼執行董事","rankno":2},{"managername":"胡兆鵬","post":"執行董事","rankno":3}],"investorinfo":[{"institutionname":"Fidelity International","shareholding":"9,514,000.0","percentage":8.98,"ReleaseDate":"2021-01-10 00:00:00","relatedparty":"富達基金(香港)有限公司","subsidiary":["Fidelity International"],"InverstorType":"基金"},{"institutionname":"Alpha Profit Holdings Limited ","shareholding":"7,928,500.0","percentage":7.48,"ReleaseDate":"2021-01-10 00:00:00","relatedparty":"李革","subsidiary":["Alpha Profit Holdings Limited "],"InverstorType":"公司"},{"institutionname":"General Atlantic Singapore OT Pte. Ltd.","shareholding":"5,285,500.0","percentage":4.99,"ReleaseDate":"2021-01-10 00:00:00","relatedparty":"General Atlantic Singapore Fund Pte. Ltd.","subsidiary":["General Atlantic Singapore OT Pte. Ltd."],"InverstorType":"公司"},{"institutionname":"TLS Beta Pte. Ltd.","shareholding":"5,285,500.0","percentage":4.99,"ReleaseDate":"2021-01-10 00:00:00","relatedparty":"淡馬錫控股(私人)有限公司","subsidiary":["TLS Beta Pte. Ltd."],"InverstorType":"公司"}],"TotalShareholdingPercentage":49.86},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":10}